European Medicines Agency (EMA) Greenlights Mitochon Pharmaceuticals to Initiate Phase I/IIa Biomarker Study in Neurodegenerative Diseases
Sponsored by:
HD Deserves a Voice; Fill Out the FDA Accelerating Access to Critical Therapies Public Docket
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
Patient Assistance Programs for INGREZZA
Help 4 HD's HD Resource Database: Phase One
This Quarter, Help 4 HD Asked a Few Questions, and the Community Responded!
A Research Study about Anonymous Genetic Testing for HD
Let's Talk About GEN HD1 and GEN HD2
FDA Grants Orphan Drug Designation for the Treatment of Huntington’s Disease
INGREZZA - For the treatment of chorea associated with Huntington's Disease (HD) TOOLKIT & RESOURCES
Help 4 HD Announces Symposium Schedules & Night Events!
Neurocrine Biosciences
Understanding the Clinical Trial Process for Huntington's Disease Families
Help 4 HD International Exhibits and Presents at the Crisis Intervention Team International (CIT)
Please stop saying that about HD...
Testing, what to do first; words from the community.
We Asked, and the Community Answered.
PTC Therapeutics Shares Positive Interim Data from PIVOT-HD Clinical Trial